Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
For tirzepatide, the SURMOUNT-1 trial published in NEJM showed average weight loss of approximately 21% of body weight at 72 weeks at the highest dose
Carefully manufactured with a strong focus on purity, consistency, and reliability, this high-quality peptide compound is designed to support professional research environments and peptide-related studies
As researchers continue to learn more about the relationship between the endocannabinoid system and digestive health, cannabinoids like THC, CBD, CBG, and CBGV may play an increasingly important role in supporting overall wellness
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Subjects References Thunander, M
Maridebart/cafraglutide (MariTide), an Antibody-peptide Conjugate Molecule Maridebart/cafraglutide, or AMG 133, is a bispecific molecule that was created by conjugating two GLP- 1 analogue agonist peptides with a fully human monoclonal anti-human GIP receptor antagonist using amino acid linkers [124]
US$ 23.37
US$ 19.99
US$ 24.48
US$ 27.51
US$ 21.20
US$ 28.94
